SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-316331
Filing Date
2020-12-14
Accepted
2020-12-14 06:05:01
Documents
14
Period of Report
2020-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d69428d8k.htm   iXBRL 8-K 47517
2 EX-10.1 d69428dex101.htm EX-10.1 55172
3 EX-10.2 d69428dex102.htm EX-10.2 242393
  Complete submission text file 0001193125-20-316331.txt   558612

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA inva-20201211.xsd EX-101.SCH 3058
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20201211_lab.xml EX-101.LAB 18139
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20201211_pre.xml EX-101.PRE 11400
7 EXTRACTED XBRL INSTANCE DOCUMENT d69428d8k_htm.xml XML 3354
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 201384994
SIC: 2834 Pharmaceutical Preparations